The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Tourism Western Australia unveils second iteration of Walking On A Dream
Feb 20: Tourism Western Australia unveiled the second iteration of ‘Walking On A Dream’, its immersive global tourism brand that…
Team Pumpkin presents Brand Buzz: Festiverse 2023
Award-winning integrated marketing agency Team Pumpkin hosted the first edition of Brand Buzz on Wednesday, September 27, 2023, in Gurugram.…
Institute of Bakery & Culinary Arts (IBCA) Announces Scholarship Worth Rs 1 Cr.
Institute of Bakery & Culinary Arts, has announced scholarships worth Rs 1 crores to enable students to build careers. The…